All translations
Jump to navigation
Jump to search
Enter a message name below to show all available translations.
Found 2 translations.
| Name | Current message text |
|---|---|
| h English (en) | ===Stages=== {| class=wikitable style="float:right; margin-left:5px" |- ! colspan = "7" | Chronic kidney disease (CKD) staging - CKD G1-5 A1-3 <br />[[glomerular filtration rate]] (GFR) and [[albumin/creatinine ratio]] (ACR) |- ! colspan="4" rowspan="5" style="border: none; background: none;"|[[File:Pfeil SO.svg|none|link=|20px]] |- ! colspan="3"| ACR |- | A1 || A2 || A3 |- | Normal to mildly increased || Moderately increased || Severely increased |- | <30 || 30–300 || >300 |- ! rowspan = "7" | G <br /> F <br /> R |- | G1 || Normal || ≥ 90 || 1 if kidney damage present || 1 || 2 |- | G2 || Mildly decreased || 60–89 || 1 if kidney damage present || 1 || 2 |- | G3a || Mildly to moderately decreased || 45–59 || 1 || 2 || 3 |- | G3b || Moderately to severely decreased || 30–44 || 2 || 3 || 3 |- | G4 || Severely decreased || 15–29 || 3 || 4+ || 4+ |- | G5 || Kidney failure || <15 || 4+ || 4+ || 4+ |- | colspan = "7" | Numbers 1–4 indicates risk of progression as well as frequency of monitoring (number of times a year). <br /> Kidney Disease Improving Global Outcomes - KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease |} |
| h Japanese (ja) | ===ステージ=== {| class=wikitable style="float:right; margin-left:5px" |- ! colspan = "7" | 慢性腎臓病 (CKD) ステージ - CKD G1-5 A1-3 <br />[[glomerular filtration rate/ja]] (GFR) と [[albumin/creatinine ratio/ja]] (ACR) |- ! colspan="4" rowspan="5" style="border: none; background: none;"|[[File:Pfeil SO.svg|none|link=|20px]] |- ! colspan="3"| ACR |- | A1 || A2 || A3 |- | 正常～軽度増加 || 中程度の増加 || 著しく増加 |- | <30 || 30–300 || >300 |- ! rowspan = "7" | G <br /> F <br /> R |- | G1 || 正常 || ≥ 90 || 腎臓に障害がある場合 1 || 1 || 2 |- | G2 || 軽度減少 || 60–89 || 腎臓に障害がある場合 1 || 1 || 2 |- | G3a || 軽度から中等度の減少 || 45–59 || 1 || 2 || 3 |- | G3b || 中等度から重度の減少 || 30–44 || 2 || 3 || 3 |- | G4 || 著しく減少 || 15–29 || 3 || 4+ || 4+ |- | G5 || 腎不全 || <15 || 4+ || 4+ || 4+ |- | colspan = "7" | 1～4の数字は、進行のリスクとモニタリングの頻度（年何回）を示す。 <br /> 腎臓病 世界的転帰の改善 - 慢性腎臓病の評価と管理に関するKDIGO 2012診療ガイドライン |} |